PPT-A n introduction to medicines development and regulation

Author : jordyn | Published Date : 2023-10-27

UKMi Horizon Scanning Working Group Jim Glare West Midlands Medicines Information Service 11Nov2018 Objectives This presentation aims to give some understanding

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "A n introduction to medicines developmen..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

A n introduction to medicines development and regulation: Transcript

UKMi Horizon Scanning Working Group Jim Glare West Midlands Medicines Information Service 11Nov2018 Objectives This presentation aims to give some understanding of the lifecycle of a medicine. Global context of drug regulation. Dr Lembit Rägo. Coordinator. Quality Assurance and Safety: Medicines. Essential Medicines and Health Products. World Health Organization. E-mail: . ragol@who.int. –. lessons from HIV. EPIP, 5 September 2017, Bordeaux. . Ellen ‘t Hoen, LLM. University Medical Centre Groningen, Global Health Unit. @. ellenthoen. www.medicineslawandpolicy.org. Brief history. Therapeutic Goods Administration. Overview. Why do we need regulation?. Who is Australia’s regulator?. How the TGA operates . Who works at the TGA. Therapeutic goods. Australian Register of Therapeutic Goods. By Laura Christian, Linda Collins, . Maythiwan. . Kiatgrajai. , . Agathe. Merle, . Nayantara. . Mukherji. , Alissa . Quade. Outline. Methodology. Overview. Definitions. Harmful Effects. Extent of the Problem. By Laura Christian, Linda Collins, . Maythiwan. . Kiatgrajai. , . Agathe. Merle, . Nayantara. . Mukherji. , Alissa . Quade. Outline. Methodology. Overview. Definitions. Harmful Effects. Extent of the Problem. [INSERT DATE HERE]. [NAME OF PRESENTER]. [TITLE OF PRESENTER]. [COMPANY NAME]. Falsified medicines – a real problem. 2. The Pharmaceutical Journal, 5. th. June 2014. Why we need a Directive . Falsified products still being found in legitimate medicines supply chain – major risk to patient safety. [INSERT DATE HERE]. [NAME OF PRESENTER]. [TITLE OF PRESENTER]. [COMPANY NAME]. Falsified medicines – a real problem. 2. The Pharmaceutical Journal, 5. th. June 2014. Why we need a Directive . Falsified products still being found in legitimate medicines supply chain – major risk to patient safety. [INSERT DATE HERE]. [NAME OF PRESENTER]. [TITLE OF PRESENTER]. [COMPANY NAME]. Falsified medicines – a real problem. 2. The Pharmaceutical Journal, 5. th. June 2014. Why we need a Directive . Falsified products still being found in legitimate medicines supply chain – major risk to patient safety. Constantinos Ziogas. SME Office, Stakeholder & Communication Division, European Medicines Agency. Open Info Day. Horizon 2020 'Health, demographic change and wellbeing‘. Brussels 22 November 2013. ealtEMA Regulatory Science to 2025Strategic rex0066006CectionContentsForeword by Prof Guido Rasi EMA Executive Director1Vision 151 Human medicines2Vision 151 Veterinary medicines41 Introduction 151 th Medicines Manufacturing in the UK 2017. Welcome by Andy Evans. Chair, MMIP. Site Lead, AZ Macclesfield. Morning Agenda. 10:00. Introduction. Steve. Thompson ABPI. Steve Bates BIA. Sue Dunkerton KTN. V2 10/14. Disclosure:. Richard Mudd, National Pharmacy Educator and Christophe Merville, . D.Pharm. , Director of Education and Pharmacy Development. are employees of Boiron.. introduction. Natural. Holis. of Pharmacy . Practice. Dr. Haider Raheem. Tracing the origins of pharmacy. Sumerians. • The development of cuneiform writing on clay tablets during the third millennium BC included lists of drugs of animal, vegetable and mineral origin that were used in the management of diseases, and prescriptions with details of the ingredients used in their compounding. Basic enquiry answering. September . 2016. Session aims. Increase awareness of the Medicines Information (MI) services. UK. Wales. Increase awareness of the questions to ask an enquirer. Have practical experience using some resources which will be...

Download Document

Here is the link to download the presentation.
"A n introduction to medicines development and regulation"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.